18F-mFBG LAFOV PET/CT Compared to 123I-mIBG Scintigraphy SPECT/CT for Evaluation of Children With Neuroblastoma

Sponsor
Rigshospitalet, Denmark
Study ID
NCT05826158
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - 18 Years
Healthy Volunteers
Not accepted

Interventions

  • 18FmFBG imaging on the Large Field of View PET/CT (Total body PET/CT) — DIAGNOSTIC_TEST
    18F-mFBG imaging on the Large Field of View PET/CT (Total body PET/CT)

Study Details

This is a study evaluating the positron-emitting radiopharmaceutical 18F-mFBG compared to 123I-mIBG scintigraphy for imaging of neuroblastoma

Key Dates

First listed
Apr 24, 2023
Start date
Jun 6, 2022
Status verified
Nov 2024
Primary completion
Sep 1, 2025
Completion
Dec 31, 2025

Study Design

Enrollment
25 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Other: Children with Neuroblastoma

Primary Outcome Measure

18F-mFBG PET Scan identification of Neuroblastoma on the LAFOV PET/CT [ Time Frame: 60 minutes ]

Central Contacts

Find similar trials

Nationwide
Neuroblastoma trialsOncology trialsPediatric oncology trials

Related Studies